Drug Trial Radar · NCT03859700
Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
Dec 6, 2018
Primary completion
May 13, 2025
Study completion May 13, 2025
Sponsor
- Lead sponsor
- DBV TechnologiesIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open-label, follow-up study for subjects who completed the EPITOPE study.
Conditions
- Peanut Allergy
Interventions
DBV712 250 mcgBiological
DBV712 250 mcg, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Were Treatment Responders at Months 12, 24, 36 and 48Time frame: Months 12, 24, 36 and 48
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Banner University Medical Center Tucson
Tucson, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
David Geffen School of Medicine at University of California Los Angeles
Los Angeles, California
Rady Children's Hospital San Diego
San Diego, California
University of California San Francisco
San Francisco, California
Stanford University School of Medicine
Stanford, California
Children's Hospital Colorado
Aurora, Colorado
Children's National Health Center
Washington D.C., District of Columbia
Children's Healthcare of Atlanta
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Comer Children's Hospital
Chicago, Illinois
Riley Hospital for Children
Indianapolis, Indiana
Johns Hopkins Hospital
Baltimore, Maryland
Boston Childrens' Hospital
Boston, Massachusetts
University of Michigan - Allergy Specialty Clinic and Food Allergy Clinic
Ann Arbor, Michigan
Mount Sinai Medical Center
New York, New York
University of Rochester
Rochester, New York
The University of North Carolina - Chapell Hill
Chapel Hill, North Carolina
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
Le Bonheur Children's Hospital
Memphis, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee
Dell Children's Medical Center of Central Texas
Austin, Texas
Children's Medical Center Dallas
Dallas, Texas
Baylor College of Medicine
Houston, Texas
Seattle Allergy & Asthma Research Institute
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.